- β66% of children who attended pump education class successfully started insulin pump therapy
- βAutomated insulin delivery (AID) systems significantly improved blood sugar control compared to standard pumps
- βRace and insurance type did not affect which type of pump system children chose once they started pump therapy
| Journal | Frontiers in endocrinology |
| Year | 2025 |
| PMID | 40538808 |
What Was This Study About?
Researchers at Children's of Alabama looked at 283 children and teens with insulin-dependent diabetes who attended a class to learn about insulin pumps (also called continuous subcutaneous insulin infusion, or CSII). They wanted to find out who actually started using a pump after the class β and whether factors like race or insurance type played a role.
What Did They Find?
Of the 283 young patients who attended the pump education class, 187 (66%) went on to start using an insulin pump, typically within about 108 days after the class.
Children who started using a pump were more likely to:
- Be younger
- Have had diabetes for a shorter time
- Have lower HbA1c levels (better blood sugar control)
- Already be using a continuous glucose monitor (CGM)
Importantly, race and insurance type were linked to whether a child started pump therapy β meaning some children faced barriers based on these factors. However, once a child did start pump therapy, race and insurance did not affect whether they chose an advanced "automated insulin delivery" (AID) system versus a standard pump.
What Are AID Systems?
An AID system combines an insulin pump with a CGM and uses smart technology to automatically adjust insulin doses. Among pump starters in this study, 62% used an AID system. These systems performed better at controlling blood sugar than standard pumps β a finding consistent with other research.
What About Pump Style?
Among those who started pumping, 70% chose a tubeless (patch) pump, which sticks directly to the skin without tubing.
Why Does This Matter?
This study highlights that there are real-world barriers β particularly around insurance coverage and racial disparities β that prevent some children from accessing insulin pump technology. The researchers are now working on ways to reduce these gaps so that all interested families can benefit from diabetes technology.
Key Takeaway
Insulin pumps, especially AID systems, can meaningfully improve blood sugar control in children with diabetes. But access isn't equal β and that's a problem worth solving.